Evidence map›Paper›PMID 39990370›Full record

ArticlebioRxiv : the preprint server for biology2025

Short 5' UTRs serve as a marker for viral mRNA translation inhibition by the IFIT2-IFIT3 antiviral complex.

Dustin R Glasner, Candace Todd, Brian Cook, Agustina D'Urso, Shivani Khosla, Elena Estrada, Jaxon D Wagner, Mason D Bartels, Pierce Ford, Jordan Prych and 12 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors.

Dustin R GlasnerSchool of Biological Sciences, University of California, San Diego, CA, USA.ORCID 0000-0001-9821-6683
Candace ToddSchool of Biological Sciences, University of California, San Diego, CA, USA.
Brian CookDepartment of Chemistry and Biochemistry, University of California, San Diego, CA USA.ORCID 0000-0002-5777-3464
Agustina D'UrsoSchool of Biological Sciences, University of California, San Diego, CA, USA.
Shivani KhoslaSchool of Biological Sciences, University of California, San Diego, CA, USA.ORCID 0000-0003-1788-3930
Elena EstradaSchool of Biological Sciences, University of California, San Diego, CA, USA.
Jaxon D WagnerSchool of Biological Sciences, University of California, San Diego, CA, USA.ORCID 0000-0001-7286-5220
Mason D BartelsTherapeutic Innovation Center, Baylor College of Medicine, Houston, Texas, USA.
Pierce FordSchool of Biological Sciences, University of California, San Diego, CA, USA.ORCID 0000-0002-6492-593X
Jordan PrychSchool of Biological Sciences, University of California, San Diego, CA, USA.
Katie HatchSchool of Biological Sciences, University of California, San Diego, CA, USA.ORCID 0000-0002-8629-0939
Brian A YeeDepartment of Cellular and Molecular Medicine, University of California, San Diego, CA USA.ORCID 0000-0001-5615-8550
Kaori M EgoDepartment of Cellular and Molecular Medicine, University of California, San Diego, CA USA.
Qishan LiangDepartment of Chemistry and Biochemistry, University of California, San Diego, CA USA.ORCID 0000-0003-4351-3140
Sarah R HollandSchool of Biological Sciences, University of California, San Diego, CA, USA.
James Brett CaseDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA.ORCID 0000-0001-7331-5511
Kevin D CorbettSchool of Biological Sciences, University of California, San Diego, CA, USA.ORCID 0000-0001-5854-2388
Michael S DiamondDepartment of Medicine, Washington University School of Medicine, St. Louis, MO, USA.ORCID 0000-0002-8791-3165
Gene W YeoDepartment of Cellular and Molecular Medicine, University of California, San Diego, CA USA.ORCID 0000-0002-0799-6037
Mark A HerzikDepartment of Chemistry and Biochemistry, University of California, San Diego, CA USA.ORCID 0000-0001-6653-6682
Eric L Van NostrandTherapeutic Innovation Center, Baylor College of Medicine, Houston, Texas, USA.ORCID 0000-0002-5188-0082
Matthew D DaughertySchool of Biological Sciences, University of California, San Diego, CA, USA.ORCID 0000-0002-4879-9603

Funding

Functional RNA elements in the human genomeR01HG004659 · NHGRI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Kevin Daniel Corbett, Eugene Wei-Ming Yeo · 2008 to 2026
$12.4M
Pathways in Biological Sciences Training ProgramT32GM133351 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Matthew Daugherty, Randolph Y. Hampton · 2020 to 2026
$9.9M
Technology Development Coordinating CenterU24HG011735 · NHGRI · JACKSON LABORATORY · PI Mark D ADAMS · 2021 to 2026
$8.1M
A comprehensive binding and functional map of human RNA-binding proteinsU24HG009889 · NHGRI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI GRAVELEY, BRENTON R., YEO, EUGENE WEI-MING · 2022 to 2025
$5.5M
STAMP technology to enable single-cell and isoform-sensitive detection of RBP sitesR01HG011864 · NHGRI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI YEO, EUGENE WEI-MING · 2021 to 2024
$4.0M
Pathogen-driven evolution of innate antiviral defense mechanismsR35GM133633 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Matthew Daugherty · 2019 to 2026
$3.3M
Molecular mechanisms of nucleic acid recognition and maintenance in meiosis and innate immunityR35GM144121 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Kevin Daniel Corbett · 2022 to 2026
$2.7M
Ribo-STAMPEDE: novel tools for molecular profiling of brain cell typesRF1MH126719 · NIMH · SCRIPPS RESEARCH INSTITUTE, THE · PI LIPPI, GIORDANO, YEO, EUGENE WEI-MING · 2022 to 2022
$2.3M
Robust, high-throughput identification of RNA processing regulators and regulatory networks genome-wideR00HG009530 · NHGRI · BAYLOR COLLEGE OF MEDICINE · PI VAN NOSTRAND, ERIC LYMAN · 2020 to 2022
$747k
Consequences of IFIT Gene Evolution on Species-Specific Antiviral ImmunityK22AI119017 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DAUGHERTY, MATTHEW · 2016 to 2017
$267k
NHGRI NIH HHS R00 HG009530NHGRI NIH HHS R01 HG004659NHGRI NIH HHS R01 HG011864NHGRI NIH HHS U24 HG009889NHGRI NIH HHS U24 HG011735NIAID NIH HHS K22 AI119017NIGMS NIH HHS R35 GM133633NIGMS NIH HHS R35 GM144121NIGMS NIH HHS T32 GM133351NIMH NIH HHS RF1 MH126719
6 · The paper itself

Abstract

Recognition of "non-self" nucleic acids, including cytoplasmic dsDNA, dsRNA, or mRNAs lacking proper 5' cap structures, is critical for the innate immune response to viruses. Here, we demonstrate that short 5' untranslated regions (UTRs), a characteristic of many viral mRNAs, can also serve as a molecular pattern for innate immune recognition via the interferon-induced proteins IFIT2 and IFIT3. The IFIT2-IFIT3 heterodimer, formed through an intricate domain swap structure resolved by cryo-EM, mediates viral mRNA 5' end recognition, translation inhibition, and ultimately antiviral activity. Critically, 5' UTR lengths <50 nucleotides are necessary and sufficient to sensitize an mRNA to translation inhibition by the IFIT2-IFIT3 complex. Accordingly, diverse viruses whose mRNAs contain short 5' UTRs, such as vesicular stomatitis virus and parainfluenza virus 3, are sensitive to IFIT2-IFIT3-mediated antiviral activity. Our work thus reveals a pattern of antiviral nucleic acid immune recognition that takes advantage of the inherent constraints on viral genome size.

Indexed as

host-virus interactionsIFIT proteinsInnate antiviral immunityinterferon-stimulated genesnon-self RNA recognitionviral mRNA translation

Identifiers

PMID39990370
PMCPMC11844544

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.